These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Influence of enzymatic induction on drug action (author's transl)]. Szczeklik A Przegl Lek; 1973; 30(7):606-9. PubMed ID: 4147844 [No Abstract] [Full Text] [Related]
24. [Problems in drug registration procedures and their significance for the physician (author's transl)]. Preisig R Ther Umsch; 1974 Nov; 31(11):859-64. PubMed ID: 4428449 [No Abstract] [Full Text] [Related]
25. [Reciprocal actions between the hepatic systems in the biotransformation of drugs and alcohol (author's transl)]. Bechtel P Therapie; 1981; 36(3):257-60. PubMed ID: 7292401 [No Abstract] [Full Text] [Related]
26. [Drug interactions. Their importance in gastroenterology]. Martín-Abréu L; Herrera JE Prensa Med Mex; 1974 Mar; 39(3-4):160-6. PubMed ID: 4409277 [No Abstract] [Full Text] [Related]
28. [Drug interference with clinical laboratory test values (author's transl)]. Tamachi H; Hine N; Nobuoka M; Yashiki T Rinsho Byori; 1974 Aug; 22(Suppl):19-31. PubMed ID: 4610223 [No Abstract] [Full Text] [Related]
29. [Testings of compatibility between diverse active compounds and excipients for tablets (author's transl)]. Jacob M; Lai AM; Duru C; Puech A; Mias F J Pharm Belg; 1979; 34(2):96-8. PubMed ID: 512824 [No Abstract] [Full Text] [Related]
30. [Editorial: A second life for medicine (author's transl)]. Glasson B Schweiz Rundsch Med Prax; 1974 May; 63(18):543-4. PubMed ID: 4831242 [No Abstract] [Full Text] [Related]
31. [Significance of biopharmaceutics for practical drug therapy]. Dettli L Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:57-63. PubMed ID: 5288609 [No Abstract] [Full Text] [Related]
32. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs. Garrett ER Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331 [No Abstract] [Full Text] [Related]
33. [Drug induced interference with clinical laboratory test procedures--identification and counterplan (author's transl)]. Nishikaze O Rinsho Byori; 1974 May; 22(5):349-51. PubMed ID: 4472782 [No Abstract] [Full Text] [Related]
34. [A "new" mechanism behind the hypersensitive reactions to drug combinations. A report from a meeting]. Naess K Tidsskr Nor Laegeforen; 1973 Jan; 93(3):183-4. PubMed ID: 4693379 [No Abstract] [Full Text] [Related]
35. BIOPHARMACEUTICS influence of formulation on THERAPEUTIC ACTIVITY 1. DEFINITIONS, SCOPE and relationship to GASTROINTESTINAL PHYSIOLOGY. Wagner JG Ann Pharmacother; 2006 Mar; 40(3):537-41. PubMed ID: 16507610 [No Abstract] [Full Text] [Related]
36. The potential clinical significance of differences in bioavailability. Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482 [No Abstract] [Full Text] [Related]
37. [The interaction of drugs in simultaneous administration in pediatric practice]. Preferanskaia NG Med Sestra; 1989 Jan; 48(1):35-8. PubMed ID: 2927292 [No Abstract] [Full Text] [Related]
39. Pharmacokinetics and their clinical significance. Garrett ER Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):193-6. PubMed ID: 5357862 [No Abstract] [Full Text] [Related]